Study points at novel approach to treat Group 3 medulloblastoma1720574891_scidaily-icon.png

Study points at novel approach to treat Group 3 medulloblastoma

A team of researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto and collaborating institutions has identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma (Gr3-MB) in the developing brain. Gr3-MB is one of the most aggressive forms of brain cancer in […]

Study points at novel approach to treat Group 3 medulloblastoma Read More »